Matthew K. Harbaugh Appointed as NuVasive's EVP & CFO

Matthew K. Harbaugh Appointed as NuVasive's EVP & CFO

NuVasive has appointed Matthew K. Harbaugh as the new Executive Vice President and Chief Financial Officer to oversee every financial aspect of the company.

FREMONT, CA: The leader in spine technology innovation, centered on transforming spine surgery, NuVasive has appointed Matthew K. Harbaugh as Chief Financial Officer and Executive Vice President. The newly appointed EVP and CFO succeeds Rajesh J. Asarpota. Mr. Harbaugh has an experience of more than 25 years in finance, business and strategy, and operations management. He will be accountable for looking after the financial aspects, comprising accounting, financial planning, and analysis, tax, and treasury of NuVasive. "With his financial, operational and leadership experience at large, global companies, Matt is an excellent fit for NuVasive as we enter our next stage of growth," says J. Christopher Barry, Chief Executive Officer of NuVasive. "We are confident that his skills and expertise will help us continue building and transforming the organization and execute our five-year strategic plan."

Mr. Harbaugh will serve as a member of the NuVasive global executive team and will report directly to Mr. Barry. The appointed EVP & CEO also served as president of the specialty generics business at Mallinckrodt plc and was Mallinckrodt's CFO for more than five years. Before joining NuVasive, he used to oversee accounting, treasury, tax functions, and financial management positions at Covidien Pharmaceuticals as a CFO. From Saint Louis University, Matthew K. Harbaugh holds a Bachelor of Science degree in Business Administration and from Kellogg School of Management at Northwestern University, an Executive Master of Business Administration degree. 

NuVasive is a pioneer in the innovation of spine technology that is centered on revolutionizing spine surgery and beyond with least disruptive, procedurally combined solutions that is designed for delivering reproducible and clinically-proven surgical results. The company believes in the global embracement of less invasive surgery to serve patients around the globe suffering from back pain. Through the integration of industry-pioneering procedures and enabling technologies, NuVasive advances the standard of care to help as many patients as they can, every year.